- Home
- KKR vs BMY Comparison
KKR vs BMY Comparison
Compare KKR & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KKR
- BMY
- Stock Information
- Founded
- KKR 1976
- BMY 1887
- Country
- KKR United States
- BMY United States
- Employees
- KKR N/A
- BMY N/A
- Industry
- KKR Investment Managers
- BMY Biotechnology: Pharmaceutical Preparations
- Sector
- KKR Finance
- BMY Health Care
- Exchange
- KKR Nasdaq
- BMY Nasdaq
- Market Cap
- KKR 108.1B
- BMY 97.6B
- IPO Year
- KKR 2010
- BMY N/A
- Fundamental
- Price
- KKR $141.06
- BMY $46.86
- Analyst Decision
- KKR Strong Buy
- BMY Hold
- Analyst Count
- KKR 16
- BMY 16
- Target Price
- KKR $152.31
- BMY $58.00
- AVG Volume (30 Days)
- KKR 3.4M
- BMY 14.3M
- Earning Date
- KKR 07-30-2025
- BMY 07-31-2025
- Dividend Yield
- KKR 0.52%
- BMY 5.29%
- EPS Growth
- KKR N/A
- BMY N/A
- EPS
- KKR 2.37
- BMY 2.67
- Revenue
- KKR $20,308,706,000.00
- BMY $47,636,000,000.00
- Revenue This Year
- KKR N/A
- BMY N/A
- Revenue Next Year
- KKR $32.32
- BMY N/A
- P/E Ratio
- KKR $59.62
- BMY $17.55
- Revenue Growth
- KKR N/A
- BMY 4.62
- 52 Week Low
- KKR $86.15
- BMY $39.93
- 52 Week High
- KKR $170.40
- BMY $63.33
- Technical
- Relative Strength Index (RSI)
- KKR 68.66
- BMY 45.47
- Support Level
- KKR $134.95
- BMY $46.33
- Resistance Level
- KKR $143.78
- BMY $48.61
- Average True Range (ATR)
- KKR 3.45
- BMY 0.92
- MACD
- KKR 0.97
- BMY 0.10
- Stochastic Oscillator
- KKR 89.50
- BMY 28.07
About KKR KKR & Co. Inc.
KKR is one of the world's largest alternative asset managers, with $664.3 billion in total managed assets, including $526.0 billion in fee-earning AUM, at the end of March 2025. The company has two core segments: asset management (which includes private markets—private equity, credit, infrastructure, energy, and real estate—and public markets—primarily credit and hedge/investment fund platforms) and insurance (following the firm's initial investment in, and then ultimate purchase of, Global Atlantic Financial Group, which is engaged in retirement/annuity and life insurance lines as well as reinsurance).
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.